Prognostic role of CIP2A expression in serous ovarian cancer
about
Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells.CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin.Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosisCIP2A influences survival in colon cancer and is critical for maintaining Myc expressionCancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer.Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomyCellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells.CIP2A is a target of bortezomib in human triple negative breast cancer cells.Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells.Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.The regulatory roles of phosphatases in cancer.Protein phosphatase 2A: a target for anticancer therapy.Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers.CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition.Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.p90/CIP2A mediates breast cancer cell proliferation and apoptosis.CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study.Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720.Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.CIP2A expression predicts recurrences of tamoxifen-treated breast cancer.CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.CIP2A is a predictor of poor prognosis in colon cancer.Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma.CIP2A overexpression is associated with c-Myc expression in colorectal cancer.CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
P2860
Q33636463-7BF0F012-32F0-4743-97F1-A0EE8264D568Q33706671-7475F6D2-DD52-498C-A527-90B5FA25510CQ33712856-8FC15C2E-F649-4B77-93A8-BC43F2ACD3D1Q33733199-71E4DA94-576E-4E73-870C-7F6252329F1BQ35009096-7887A672-E707-42FD-8B3E-BFFAB9DECDD2Q35055737-D1CF6E65-5DF9-4221-BBA1-08A900EE9207Q35503680-9B662A63-F114-484D-9994-DB30235FB07EQ35755402-6121FAD6-B653-43AE-BFA9-071EC6F38AC0Q35986590-A39690CF-13A5-4976-8E7C-668E0A3D2015Q36245640-050A9593-D098-4D24-80B1-A5E38A1648E8Q36273561-F8A726FD-7AFD-452A-8290-36D19F304B41Q36777896-DB5C9DC6-88E6-40D3-ACC0-15ED7B9537DDQ36814489-7D90E14B-C157-46F6-BC8C-37434132F9BDQ37428639-CB0DB4F8-DC41-4784-90BC-F78EC4509750Q38090432-65D5BC65-741F-4CC0-913F-487FDF73BAC7Q38103646-23AEAB4F-91AE-4065-B82D-69E70AF5CA5CQ38228491-0229507B-DDAE-4940-8AA6-F7ACF6797E5EQ38335027-565D5530-DBFC-41D7-B0C0-CE8031E6E6ACQ38401447-633F73EC-A43E-4727-9173-6E983277A02EQ38617799-778512F8-7DF1-4EC1-952C-4F1480EC3CDEQ38710692-F9E89949-12A4-492E-9564-FD2F5849ABA0Q38891984-3DE88B7A-2725-45ED-BFB9-D973FEF61129Q38903935-757F6465-4223-4A52-A72C-3D51B91C271DQ38904928-E746C375-26D5-4961-A242-AB004477BEC4Q38914929-99D35127-BB77-4630-84BD-A488D058C0D8Q38969283-B7BEB533-5107-4A88-8A78-1EBF68E2B912Q39098575-E0352E0F-1251-44A3-AA1D-B43082252533Q39218849-AA3FEEF2-5BFB-45AF-8899-C76764A5C9DBQ41814891-A8718E91-B1E6-424A-ACEA-7752DCC5D423Q41913139-6789622E-37B1-40B9-9A32-25EB886BFB5BQ41922459-86E6A7B6-01DC-4FEE-80B3-AE23A18027F3Q47110572-4C1FAA01-1A88-49C8-BD62-EE166C3682D4Q47271622-1FB67031-08A0-4B34-A10C-901D94007D52Q47649534-63C250F1-9271-4A3A-BF30-D2D794632114Q47832427-6FB2383D-B320-477E-8FB9-F091EA61B001Q48733192-905E5915-685A-494D-9C3F-E5785EAD1E98Q50019901-22AD9E2A-FB21-43A1-901D-634A1F1EDB94Q50876945-D97E2471-E4DC-449E-B36D-6D5FCC9714E4Q50969099-C4D7D73A-FFA2-4A4B-8919-65AD88359DBAQ51020266-28F475DA-571B-4317-B304-5D3991CD2DC6
P2860
Prognostic role of CIP2A expression in serous ovarian cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prognostic role of CIP2A expression in serous ovarian cancer
@ast
Prognostic role of CIP2A expression in serous ovarian cancer
@en
type
label
Prognostic role of CIP2A expression in serous ovarian cancer
@ast
Prognostic role of CIP2A expression in serous ovarian cancer
@en
prefLabel
Prognostic role of CIP2A expression in serous ovarian cancer
@ast
Prognostic role of CIP2A expression in serous ovarian cancer
@en
P2093
P2860
P50
P356
P1476
Prognostic role of CIP2A expression in serous ovarian cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.346
P407
P577
2011-09-06T00:00:00Z